Medtronic

1Exits tracked$650mDisclosed value$650mMedian price0Acquihires

Photo: Group29 at English Wikipedia / Wikimedia Commons, CC BY-SA 3.0

Medtronic agrees to buy SPR Therapeutics for $650 million in cash

The Cleveland company's SPRINT PNS system treats pain with 60 days of nerve stimulation and no permanent implant, giving Medtronic an earlier option in its pain portfolio.

Price$650mRaisedn/aLast stageSeries D+Buyer typeCorporate

Latest in MedtronicMore stories here soon.

All Medtronic exitsOpen tracker →

20 MayMedtronic → SPR TherapeuticsCleveland · Series D+ · raised n/a$650m$250m–1bn